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Abstract 
Influenza A virus (H1N1), a genetic reassortment of endemic strains of human, avian and swine flu, has crossed 
species barrier to human and apparently acquired the capability of human to human transmission. Some strains of 
H5N1 subtype are highly virulent because NS1 protein inhibits antiviral interferon α/β production. Another pro-
tein NS2 mediates export of viral ribonucleoprotein from nucleus to the cytoplasm through export signal. In this 
paper, we have studied structure-function relationships of these proteins of H1N1 subtype and have determined 
the cause of their pathogenicity. Our results showed that non-conservative mutations slightly stabilized or destabi-
lized structural domains of NS1 or NS1-dsRNA complex, hence slightly increased or decreased the function of 
NS1 protein and consequently enhanced or reduced the pathogenicity of the H1N1 virus. NS2 protein of different 
strains carried non-conservative mutations in different domains, resulting in slight loss of function. These muta-
tions slightly decreased the pathogenicity of the virus. Thus, the results confirm the structure-function relation-
ships of these viral proteins. 
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Introduction  
Influenza A virus causes annual epidemic and occa-
sional pandemics due to its contagious nature and 
high mutation rate, possessing significant challenge to 
both human and animal health. In April 2009, a novel 
H1N1 virus was detected in several cases showing 
influenza-like illness in California and was subse-
quently recognized to be the cause of a major out-
break of respiratory disease in Mexico (1). The virus 
was found to be an H1N1 virus that was genetically 
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and antigenically unrelated to human seasonal influ-
enza viruses but genetically related to viruses circu-
lating in swine (2-5). The virus was subsequently 
confirmed in patients from many countries around the 
world (6). The pandemic extends into 2010, although 
their number declined considerably (7). The virus is a 
reassortment of four known strains of influenza A vi-
rus, one endemic in human, one endemic in bird and 
two endemic in swine (8). This H1N1 virus has 
crossed species barrier to human and apparently ac-
quired the capability of human to human transmission 
(9, 10), therefore this virus is currently of grave con-
cern to public health authorities.  
Influenza A virus belongs to the family of Ortho-
myxoviridae. It is a lipid-enveloped virus with a 
This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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negative single-stranded sense RNA genome con-
sisted of eight separate segments. These segments 
code for eleven proteins (11, 12), including hemag-
glutinin (HA), neuraminidase (NA), matrix protein 
M1, ion-channel M2, non-structural proteins NS1 and 
NS2, nucleoprotein NP, pro-apoptotic protein PB1-F2, 
and RNA-dependent RNA polymerase PA, PB1 and 
PB2 (13).  
Non-structural proteins NS1 and NS2 are coded by 
the eighth segment of viral RNA. The non-structural 
genes contain 890 nucleotides (nt) including open 
reading frames (14). The NS2 mRNA contains a 473 
nt intron. NS1 and NS2 genes have two overlapping 
sequences: a 56 nt leader sequence containing initia-
tion codon (AUG) before the intron, and a 210 nt se-
quence after the intron (14). In the infected cell, NS1 
is localized in the nucleus and NS2 in the cytoplasm. 
NS1 is a multifunctional protein that plays an impor-
tant role as a post-transcriptional regulator in the in-
fluenza virus life cycle: it binds virion RNA (15-17), 
poly(A)-containing RNA (18), U6 snRNA (19), and 
some viral and cellular proteins. Some strains of 
H5N1 subtype are highly virulent because NS1 pro-
tein inhibits antiviral interferon α/β production (20). 
NS1 protein contains 230-237 amino acids depending 
upon the strain, and has a molecular mass of ap-
proximately 26 kDa (21). It has two major domains 
(16, 17, 22): the first is an RNA-binding domain lo-
cated in the N-terminal region (residues 1-73), which 
protects the virus against the antiviral state induced by 
IFN α/β by blocking the activation of 2'-5' oligo(A) 
synthetase/RNase L pathway; the second is a 
C-terminal domain (from residue 74 to the end), 
which is an effector domain containing several other 
domains, including cleavage and polyadenylation 
specificity factor (CPSF)-binding domain (residues 
175-210), poly(A)-binding protein (PABP) domain 
(residues 218-225), nuclear localization signal 1 
(residues 34-38), nuclear localization signal 2 (resi-
dues 211-216), nuclear export signal (residues 
132-141) and e1F4G1 domain (residues 81-113) (20). 
The effector domain interacts with a large number of 
viral and cellular factors, such as the virus polymerase 
and ribonucleoprotein (RNP) (17), which are cellular 
proteins involved in translation and post-transcriptional 
processing of RNA (22-28). Such interactions may 
alter cellular gene expression (22, 25, 29-31), virus 
gene expression (32, 33), and may also block the sig-
naling pathway mediated by Jun N-terminal protein 
kinase (34) and down-regulate apoptosis (35). More-
over, NS1 plays a crucial role in protecting the influ-
enza virus against the cellular cytokine response (36, 
37).  
The NS2 protein was previously thought to be pre-
sented only in infected cells, until it was shown to 
exist in the viral particle (38). It is also referred to as 
nuclear export protein (NEP) because it plays an im-
portant role in mediating the export of viral RNP from 
nucleus to the cytoplasm through export signal and 
via interaction with Crm1 protein (39, 40). The NS2 
protein is involved in viral assembly by interacting 
with the M1 protein (41). Recently, it has been pro-
posed that NS2/NEP protein regulates influenza virus 
transcription and replication that is independent of its 
viral RNP export function (42). NS2 protein consists 
of 121 amino acid residues and has a molecular mass 
of approximately 15 kDa (43). Important domains of 
NS2 protein have been reported, such as the influenza 
M1 protein binding region (residues 59-116) and nu-
clear export signal (residues 11-23) (39, 44, 45). Ex-
cept for the first nine amino acids, these NS1 and NS2 
proteins do not bear structural relationship for the rest 
of polypeptide chain containing several domains with 
different function. In view of significant role of these 
proteins in virus life cycle, we have selected NS1 and 
NS2 proteins of different strains with the main objec-
tive to identify mutations in different structural do-
mains of NS proteins and thus to deduce their struc-
ture-function relationships and consequently deter-
mine the exact cause of pathogenicity of H1N1 virus. 
Furthermore, we have also analyzed mutations in the 
antigenic sites of NS proteins.  
Results and Discussion 
Sequences with more than 90% identity show similar 
structure and function. In the present study, we have 
compared the sequences of NS1 and NS2 of H1N1 
strains ACR08506 and ACR08507, respectively, with 
those of other strains showing identity greater than 
90%. We have identified mutations in different do-
mains of these proteins and deduced their struc-
ture-function relationships.   
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Structure-function analyses of NS1 protein 
Previous studies have shown that high levels of inter-
feron α/β and its mRNA were produced in cells in-
fected with a recombinant A/wisconsin/33 (AWSN/33) 
containing a mutation in RNA-binding domain (46, 
47). The experimental studies on recombinant 
A/Udorn/72 virus revealed that the RNA-binding do-
main of NS1A protein does not inhibit the influenza A 
virus induced by synthesis of interferon-β mRNA; 
however, it is required for the production of influenza 
A virus against antiviral state induced by interferon-β. 
The NS1 protein antagonizes the interferon α/β pro-
duction by inhibiting 2′-5′ oligo(A) synthetase/RNase 
L pathway (48). 
The sequence of NS1 protein of strain ACR08506 
was compared with the sequences of NS1 of other 
strains, resulting in 99.54% to 99.08% identity, and 
mutations were identified in different structural do-
mains of NS1. Eighteen sequences of NS1 were se-
lected in this study (Table 1). A large number of 
strains (ACT68236, ACQ76393, ACR67137, 
ACT79188, ACQ76301, ACT68220, ACQ83304 and 
ACT86044) showed mutations in the RNA-binding 
domain (Table 2). 
Table 1  NS1 sequence dataset from human source 
Strain Accession No. Country 
A/New Mexico/04/2009(H1N1) ACR08506 Mexico 
A/Kobe/1/2009(H1N1) ACR54020 Japan 
A/Utsunomiya/1/2009(H1N1) ACS92605 Japan 
A/Canada-MB/RV2013/2009(H1N1) ACT68236 Canada 
A/Nebraska/02/2009(H1N1) ACQ76393 USA 
A/North Dakota/04/2009(H1N1) ACR67137 USA 
A/Brawley/40081/2009(H1N1) ACT79148 USA 
A/Italy/85/2009(H1N1) ACT10313 Italy 
A/Bethesda/SP508/2009(H1N1) ACT79188 USA 
A/Caen/2716/2009(H1N1) ACS91361 France 
A/New York/3460/2009(H1N1) ACT83860 USA 
A/Stockholm/34/2009(H1N1) ACT21950 Russia 
A/Canada-SK/RV1767/2009(H1N1) ACT68220 Canada 
A/Canada-NS/RV1538/2009(H1N1) ACQ89930 Canada 
A/Texas/15/2009(H1N1) ACQ83304 USA 
A/New York/3184/2009(H1N1) ACR77453 USA 
A/New York/3501/2009(H1N1) ACT86044 USA 
A/Minnesota/02/2009(H1N1) ACQ76353 USA 
Table 2  Amino acid mutations in NS1 protein of different strains at specific positions and their location in different domains 
Accession No. Mutation at specific position Location of mutation in domains Hydrophobicity change (Kyte & Doolittle) 
ACR54020 V178→I178 CPSF-binding domain +1.656 → +1.689 
ACS92605 R204→K204 CPSF-binding domain −1.478 → −1.411 
ACT68236 L33→F33 RNA-binding domain −0.600 → −0.711 
ACQ76393 D12→ E12 RNA-binding domain +0.822 → +0.822 
ACR67137 D24→N24 RNA-binding domain −0.867 → −0.867 
ACT79148 I111→T111 e1F4G1-binding domain −0.300 → −0.878 
ACT10313 I112→M112 e1F4G1-binding domain +0.156 → −0.133 
 I123→V123 − −0.656 → −0.689 
ACT79188 A57→T57 RNA-binding domain +0.611 → +0.333 
 I123→V123 RNA-binding domain −0.656 → −0.689 
ACS91361 I123→V123 − −0.656 → −0.689 
 A202→T202 CPSF-binding domain −0.589 → −0.867 
ACT83860 F103→L103 e1F4G1-binding domain −0.100 → +0.010 
ACT21950 G189→D189 CPSF-binding domain −1.000 → −1.344 
ACT68220 D55→G55 RNA-binding domain +0.567 → +0.911 
ACQ89930 D97→G97 e1F4G1-binding domain −0.989 → −0.644 
ACQ83304 G45→R45 RNA-binding domain −1.589 → −2.044 
ACR77453 D92→G92 e1F4G1-binding domain −0.533 → −0.189 
ACT86044 I123→V123 − −0.656 → −0.689 
 F34→S34 RNA-binding domain −0.711 → −0.710 
ACQ76353 R88→C88 e1F4G1-binding domain −0.578 → +0.200 
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The biophysical study has demonstrated that two 
basic amino acids, Arg38 and Lys41, are the only 
amino acids that are required for the dsRNA binding 
(49). The actual crystal structure of NS1 in complex 
with dsRNA is not solved yet. So a detailed view of 
amino acids that participate in dsRNA binding is not 
available. However, we can predict which amino acid 
participates in dsRNA binding by identifying the na-
ture of amino acid mutations and their consequences 
on the protein function.  
The NS1 protein of strain ACT68236 carried 
non-conservative mutation in RNA-binding domain 
where Leu33 was replaced by Phe33. The conforma-
tion of RNA-binding domain was not altered. In the 
mutant strain, an aromatic Phe33 probably formed 
hydrophobic interaction with ribose ring of dsRNA, 
which leads to increase in its binding. Hence, the 
complex was stabilized and the virus propagated in 
the host and increased its pathogenicity. This observa-
tion is validated by recent experimental findings that 
showed recombinant influenza A virus expressing 
RNA-binding defective NS1 protein induced high 
levels of interferon-β production and was attenuated 
in mice (46). 
NS1 of strain ACQ76393 showed mutation at 
Asp12→Glu12. The Asp12 forms an electrostatic in-
teraction with Arg26 at the dimer interface (50, 51). 
Since this is a synonymous mutation (Asp12 to 
Glu12), it did not abolish electrostatic interaction with 
Arg26. Hence the structure as well as dimerization of 
NS1 was not affected and it remains binding to 
dsRNA. The interferon α/β was not synthesized; 
therefore, this strain was virulent. In ACR67137 strain, 
there was Asp24→Asn24 conservative substitution 
that did not change the structure or microenvironment 
of RNA-binding domain of NS1 protein. Hence, mu-
tant strain binds dsRNA normally and it was patho-
genic in nature.  
NS1 of strain ACT79188 carried double mutations, 
one is non-conservative mutation Ala57→Thr57 and 
the other is conservative mutation I123→V123. The 
non-conservative mutation occurred in RNA-binding 
domain. In the mutant strain the amino acid Thr57 
formed hydrogen bond with OH of the ribose of 
dsRNA. Since the structure of RNA-binding domain 
and complex was stabilized, this strain was found to 
be pathogenic. In ACT86044 strain, non-conservative 
mutation occurred in RNA-binding domain, where an 
aromatic Phe34 was mutated to polar Ser34. There 
was a loss of hydrophobic interaction that occurred 
between Phe34 and ribose ring of dsRNA, but gain of 
hydrogen bonding between Ser34 and OH of ribose. 
Since hydrogen bonding is a weak interaction com-
pared with hydrophobic interaction, therefore NS1 of 
this strain binds weakly to dsRNA. The interferon α/β 
was produced. Consequently this strain shows weak 
pathogenicity. 
The three-dimensional structure of NS1 (residues 
1-73) shows that there is strong hydrophobic interac-
tion between residues in helix 3 (Ile54-Lys70) and 
residues in other helices in the dimeric structure (50, 
51). These interactions are vital for stabilizing this 
domain structure. In NS1 of strain ACQ68220, there 
was a non-conservative mutation where an acidic 
Asp55 was mutated to hydrophobic Gly55 in helix 3 
of RNA-binding domain. This leads to hydrophobic 
interaction between Gly55 and other hydrophobic 
residues of other helix. Hence, the dimeric structure 
of NS1 was slightly stabilized. Thus, NS1 of this 
strain increasingly binds the dsRNA. Interferon α/β 
was not produced. The virus propagated and increased 
its pathogenicity. 
In strain ACQ83304, a non-conservative mutation 
occurred, where Gly45 was substituted by Arg45 in 
RNA-binding domain. Recent study suggests that 
Gly45 is one of the conserved amino acids that en-
hanced the stability of NS1-dsRNA complex (52). 
However, in the mutant strain Arg45 also enhanced 
the stability of NS1-dsRNA complex by forming an 
electrostatic interaction with phosphate backbone of 
dsRNA. Therefore, this strain was pathogenic. These 
results imply that besides Arg38 and Lys41, other 
amino acids like Phe33, Thr57, Gly55 and Arg45 of 
NS1 protein might also contribute to dsRNA binding 
by stabilizing the structural domains of NS1 or com-
plex of NS1-dsRNA. Hence these amino acids facili-
tate pathogenicity in viral strains. 
In NS1 of strain ACR77453 of H5N1 subtype, mu-
tation Asp92 to Gly92 occurred in e1F4G1-binding 
domain. Recent studies showed that Asp92→Glu92 
mutation in NS1 protein of H5N1 subtype is associ-
ated with increase in mRNA binding hence increase in 
virulence, cytokine resistance or both (53, 54). A mo-
lecular modeling study (55) showed that Asp92→Glu92 
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mutation in NS1 protein of H5N1 subtype could cause 
weakened hydrogen bonding interactions of the car-
boxylate side chain of Glu with other residues such as 
Ser195 and Thr197. Thus, these two residues exist in 
a free state and are available for interactions with host 
targets or for phosphorylation, which thus increased 
the pathogenicity of this mutant (55). In NS1 of the 
strain ACR77453 of subtype H1N1, Asp92 with a 
longer side chain was substituted by Gly92 with a 
smaller side chain. This leads to loss of hydrogen 
bonding interaction between short side chain of Gly 
and polar Ser195 and Thr197. Therefore, these two 
residues Ser195 and Thr197 exist in free state and 
undergo phosphorylation or interact with host target. 
Thus, this increased the pathogenicity of ACR77453 
strain. 
The NS1 of some strains showed mutation at 
CPSF-binding domain (Table 2). In strains ACR54020 
and ACS92605, conservative mutations occurred in 
CPSF-binding domain, where a hydrophobic amino 
acid is substituted by another hydrophobic amino acid 
(V178→I178) and a basic amino acid is substituted 
by another basic amino acid (R204→K204). These 
mutations did not change either structural or microen-
vironmental property of CPSF-binding domain. 
Therefore, NS1 proteins of these two strains bind cel-
lular protein CPSF. Hence in these two mutants, ade-
nylation of 3' mRNA and interferon α/β was inhibited. 
Therefore, these strains were pathogenic. This obser-
vation is supported by an experimental study, which 
showed that influenza A virus NS1 protein binds to 
the cellular 30 kDa subunit of CPSF and inhibits 3' 
end formation of cellular pre-mRNAs and therefore is 
pathogenic (25). 
NS1 of strains ACS91361 and ACT21950 carried 
non-conservative mutation in CPSF-binding domain 
(Table 2). Therefore, both the structural stability and 
microenvironment of CPSF-binding domain was 
slightly changed. The NS1 protein binds weakly to 
CPSF protein. This leads to low levels of adenylation 
of the 3'-pre-mRNA including interferon α/β. Hence 
these strains were less pathogenic.  
The rest strains ACT79148, ACT10313, ACT83860, 
ACQ89930 and ACQ76353 carried non-conservative 
mutations in e1F4G1 domain of NS1. In these strains, 
the structure of e1F4G1 domain was destabilized and 
the hydropathy-index of this domain was changed. 
The NS1 of these strains binds weakly to e1F4G1. 
Hence, translation of viral mRNA was slowed. 
Therefore, these strains showed weak pathogenicity. 
Earlier study has demonstrated that the role of 
C-terminal of NS1 protein in vivo is to stabilize and/or 
facilitate NS1 dimer or multimer formation; therefore 
it promotes RNA binding function of NS1 N-terminal 
domain (56). Mutations observed here in CPSF-binding 
domain or e1F4G1 domain influenced dimerization or 
multimerization of NS1, hence it affected RNA bind-
ing function of NS1 protein. These studies showed 
that the consequences of non-conservative mutations 
in structural domains of different NS1 strains were 
varied. It either slightly stabilized or destabilized the 
structure or complex of NS1 hence enhanced or re-
duced the pathogenicity of the H1N1 virus. The 
structure of NS proteins of some strains was slightly 
altered, therefore they were less pathogenic. Thus, this 
study showed that NS proteins of this pandemic strain 
H1N1 caused mild severity. 
Antigenicity of NS1 protein 
Table 3 shows the antigenicity profile of NS1 in 
strain ACR08506. Ten antigenic sites have been pre-
dicted by computer program “Antigenic”. This anti-
genicity profile was found common in all strains 
studied except in ACT68236, which showed mutation 
Leu33→Phe33. Therefore, antigenic segment 29-35 
was missing from this strain. This is a major change 
that occurred at the antigenic sites of this strain, 
which may be one of the causes of antigenic varia-
tions in NS1 protein (Table 3). It is more pathogenic 
since antibody binding site is lost and viral neutraliza-
tion may not take place. Other strains (ACT79148, 
ACT10313 and ACT83860) showed minor changes at 
the antigenic sites (100-122). Strains ACT79198 and 
ACT68220 carried mutations in antigenic segment 
(55-68). Strains ACR54020, ACQ76393 and 
ACQ76353 showed mutations in antigenic segments 
174-184, 8-18 and 80-90, respectively. Hence, all of 
these strains escaped antibody binding and viral neu-
tralization phenomenon. The internal proteins like 
NS1 or NS2 do not mutate as fast as surface proteins 
HA and NA. Most recently, recombinant influenza 
viruses with truncated or mutated NS1 proteins have 
been used as promising live-attenuated virus vaccines  
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Table 3  Predicted antigenic sites in NS1 protein 
Amino acid position Antigenic segment No. of amino acid residues Score 
108-122 RQKIIGPLCVRLDQA 15 1.184 
8-18 SFQVDCFLWHI 11 1.158 
55-68 ETATLVGKQIVEWI 14 1.141 
174-184 VKNAVGVLIGG 11 1.140 
141-149 LETLILLRA 9 1.133 
154-169 GAIVGEISPLPSLPGH 16 1.115 
80-90 TIASVPTSRYL 11 1.093 
126-139 KNIVLKANFSVIFN 14 1.092 
29-35 DAPFLDR 7 1.066 
192-197 VRVSEN 6 1.061 
29-35 (ACT68236) DAPFLDR (Antigenic segment missing) − − 
 
(57-61). Thus, recombinant vaccines containing anti-
genic epitopes of internal proteins NS would be an 
effective measure in preventing the rapid spread of 
H1N1 virus infection. 
Structure-function analyses of NS2 protein 
The NS2 protein is involved in virus assembly through 
its interaction with M1 protein (41). It has M1 protein 
binding region and nuclear export signal. The crystal 
structure of C-terminal (M1-binding domain) NS2 
showed that helical hairpin is amphipathic in nature, 
with one face hydrophobic and the other face hydro-
philic (45). The hydrophobic face contains 16 of 21 hy-
drophobic residues whereas the hydrophilic face has 15 
of 19 charge residues. Six glutamate side chains cluster 
near the centre of hydrophilic face surrounding Trp78. 
The hydrophobic face of one helix is buried against 
second hairpin helical structure. Hence, there are large 
numbers of glutamates present near Trp78. These glu-
tamates will form electrostatic interactions with basic 
nuclear localization signal (NLS) of M1 protein. 
We compared the sequence of NS2 protein of strain 
ACR08507 with NS2 proteins of other strains, result-
ing in 99.52% to 98% identity. Twelve sequences of 
NS2 of H1N1 subtype were selected (Table 4). There 
are several strains having mutation in M1-binding 
region (Table 5), including ACR54980, ACR56358, 
ACT67144, ACQ84455, ACQ83305, ACS91365, 
ACR67131, ACQ89931 and ACP52563. 
Strains ACQ84455 and ACQ83305 carried muta-
tions in M1-binding region of NS2 at position 63 and 
67 (Glu63→Lys63 and Glu67→Lys67), respectively. 
Since Trp78 is surrounded by a large number of glu-
tamates at the charge surface of M1-binding region, 
presence of mutated basic amino acid in strains 
ACQ84455 and ACQ83305 decreased the acidity 
around Trp78, and the two mutated basic amino acids 
Lys63 and Lys67 did not form electrostatic interaction 
with basic NLS of M1 protein (45). Therefore, virus 
assembly was slightly inhibited and the NS2 proteins 
of these two strains are less virulent. 
NS2 of strain ACS91365 showed mutation in 
M1-binding region at position 89 (Ala89→Thr89). 
The crystal structure of C-terminal domain (M1-binding 
region) of NS2 protein showed that eight residues 
forming an interhelical turn are well ordered, includ-
ing two hydrophobic residues that are partially buried 
between the helices (45). In ACS91365 strain, muta-
tion occurred in an interhelical region where hydro-
phobic Ala89 is substituted by polar Thr89. The  
Table 4  NS2 sequence dataset from human source 
Strain Accession No. Country
A/New Mexico/04/2009(H1N1) ACR08507 Mexico
A/Shanghai/1/2009(H1N1) ACR54980 China 
A/Guangdong/03/2009(H1N1) ACR56358 China 
A/CastillaLaMancha/GP369/2009(H1N1) ACT67144 Spain 
A/Korea/01/2009(H1N1) ACQ84455 Korea 
A/Texas/15/2009(H1N1) ACQ83305 USA 
A/New York/3203/2009(H1N1) ACR77484 USA 
A/Paris/2670/2009(H1N1) ACS91365 France 
A/Arizona/07/2009(H1N1)  ACR67131 USA 
A/Canada-NS/RV1538/2009(H1N1) ACQ89931 Canada
A/California/06/2009(H1N1) ACP52563 USA 
A/Texas/19/2009(H1N1) ACS72585 USA 
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Table 5  Amino acid mutations in NS2 protein of different strains at specific positions and their location in different domains 
Accession No. Mutation at specific position Location of mutation in domains Hydrophobicity change (Kyte & Doolittle) 
ACR54980 R86→K86 M1-binding domain −1.422 → −1.356 
ACR56358 E67→D67 M1-binding domain −2.211 → −2.211 
ACT67144 K64→R64 M1-binding domain −3.178 → −3.224 
ACQ84455 E63→K63 M1-binding domain −3.178 → −3.222 
ACQ83305 E67→K67 M1-binding domain −2.211 → −2.256 
ACR77484 M16→I16 Nuclear export signal +0.144 → +0.433 
ACS91365 A89→T89 M1-binding domain −1.611 → −1.889 
ACR67131 A115→V115 M1-binding domain −0.433 → −0.167 
ACQ89931 A115→T115 M1-binding domain −0.433 → −0.711 
ACP52563 A189→E189 M1-binding domain −1.611 → −2.200 
ACS72585 G22→E22 Nuclear export signal −0.889 → −1.233 
Table 6  Predicted antigenic sites in NS2 protein of different strains 
Accession No. Amino acid position Antigenic segment No. of amino acid residues Score 
99-112 FMQALQLLLEVEQE 14 1.178 
ACR08507 
37-43 SLKIYRD 7 1.064 
ACQ84455 55-60 LHYLQS (Gain of antigenic segment) 6 1.095 
ACR77484 10-15 QDILMR (Gain of antigenic segment) 6 1.057 
ACS91365 54-59 DLHYLQ (Gain of antigenic segment) 6 1.095 
ACR67131 112-118 EIRVFSF (Gain of antigenic segment) 7 1.142 
ACQ89931 54-59 DLHYLQ (Gain of antigenic segment) 6 1.095 
ACP52563 54-59 DLHYLQ (Gain of antigenic segment) 6 1.095 
 
mutated amino acid Thr89 is polar in nature therefore 
it is not buried between the helices. Hence, the con-
formation and microenviroment of M1-binding do-
main was slightly changed. It binds weakly to M1 
protein and consequently slightly inhibits virus as-
sembly and causes mild pathogenicity. In strain 
ACQ89931, mutation occurred in helix C2 where hy-
drophobic Ala115 was replaced by polar Thr115. Due 
to the presence of polar Thr in hydrophobic surface of 
M1-binding domain, the microenvironment of this 
domain was changed. Thus, hydrophobic interaction 
occurring between helix C2 and C1 of same or dif-
ferent monomer was slightly inhibited (45). This leads 
to slight inhibition of virus assembly and the strain 
may be less virulent. 
NS2 of ACP52563 strain was found to be substi-
tuted from hydrophobic Ala189 to charged Glu189 in 
the hydrophobic surface of M1-binding domain. The 
hydrophobicity of the surface decreased slightly, 
hence it interacts weakly with hydrophobic surface of 
same or other monomer of NS2 (45). This may again 
lead to slight inhibition of virus assembly and weak 
pathogenicity.  
Recent findings indicate that methionine at positions 
14, 16, and 19 and leucine at position 21 of the se-
quence are important for nuclear export sequence (NES) 
function (40). In the strain ACR77484 amino acid, Met 
at position 16 was substituted by Ile in NES region. 
Therefore, export of vRNP was slightly inhibited. In 
ACS72585 strain, hydrophobic Gly22 was substituted 
by an acidic Glu22 in NES region. The NS2 of this 
strain is not easily exported through nuclear membrane 
because of charged amino acid at position 22 (Glu22). 
Hence, these strains showed weak virulence. 
Antigenicity of NS2 protein 
Table 6 shows the antigenicity profile of NS2 protein. 
Two antigenic sites appeared in ACR08507 strain. A 
third antigenic site also appeared in other strains 
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(ACQ84455, ACR77484, ACS91365, ACR67131, 
ACQ89931 and ACP52563). These antigenic sites 
are present at the N and C terminal of protein. These 
regions are a little bit more exposed in most of the 
proteins. Recently, recombinant influenza viruses 
with truncated or mutated internal protein like NS1 
have been used as promising live-attenuated virus 
vaccines (60, 61). Hence these antigenic segments of 
NS2 are important targets for drug and antiviral vac-
cine developments. 
Conclusion 
Our studies conclusively showed that the conse-
quences of non-conservative mutations occurring in 
different structural domains of NS1 of H1N1 strains 
were varied. It either slightly stabilized or destabilized 
structural domains of NS1, hence slightly increased or 
decreased the function of NS1 protein and conse-
quently enhanced or reduced the pathogenicity of the 
H1N1 virus. NS2 proteins of different strains carrying 
non-conservative mutations showed a slight alteration 
in structure and/or microenvironment of domains, 
hence the function of virus was slightly inhibited and 
consequently decreased the pathogenicity of the virus. 
Thus, these studies justify the structure-function rela-
tionships of the viral NS1 and NS2 proteins.  
Materials and Methods 
The NS1 and NS2 protein sequences were downloaded  
from NCBI (http://www.ncbi.nlm.nih.gov/), subjected  
to protein-protein blast (http://www.ncbi.nlm.nih.gov/ 
BLAST/), and aligned by ClustalW multiple align- 
ment tool using weight matrix GONNET for proteins  
(http://npsa-pbil.ibcp.fr/cgi-bin/npsa_automat.pl?page=  
npsa_clustalw.html). These aligned sequences were  
analyzed for mutations in amino acids at specific  
positions in important structural domains. Hydropho- 
bicity values were obtained from the tool ProtScale at  
ExPASy server by selecting Kyte & Doolittle hydro- 
phobicity scale (http://www.expasy.org/tools/protscale.  
html). These proteins were also subjected to antigenic 
analysis using program “Antigenic” (http://liv.bmc.uu.  
se/cgi-bin/emboss/antigenic). 
Acknowledgements 
This work was supported by the DBT grant sanction 
No. BT/PR7507/BID/07/201/2006 to AUK. Authors 
are also grateful to Prof. M. Saleemuddin for provid-
ing the internal fund for this project. 
Authors’ contributions 
PS collected the dataset, performed data analyses and 
drafted the manuscript. AUK designed the study, su-
pervised the project and co-wrote the manuscript. 
Both authors read and approved the final manuscript. 
Competing interests 
The authors have declared that no competing interests 
exist. 
References 
1 Neumann, G., et al. 2009. Emergence and pandemic 
potential of swine-origin H1N1 influenza virus. Nature 
459: 931-939.  
2 Brown, I.H. 2000. The epidemiology and evolution of in-
fluenza viruses in pigs. Vet. Microbiol. 74: 29-46.   
3 Olsen, C.W. 2002. The emergence of novel swine influ-
enza viruses in North America. Virus Res. 85: 199-210. 
4 Webby, R.J., et al. 2000. Evolution of swine H3N2 influ-
enza viruses in the Unites States. J. Virol. 74: 8243-8251. 
5 Gordon, S.M. 2009. Update on 2009 pandemic influenza 
A (H1N1) virus. Cleve. Clin. J. Med. 76: 577-582. 
6 Shinde, V., et al. 2009. Triple-reassortant swine influenza 
A (H1) in humans in the United States, 2005-2009. N. 
Engl. J. Med. 360: 2616-2625.  
7 Centers for Disease Control and Prevention (CDC). 2010. 
Update: influenza activity-United States, August 30, 
2009-March 27, 2010, and composition of the 2010-11 
influenza vaccine. Morb. Mortal. Wkly. Rep. 59: 423-430. 
8 Smith, G.J., et al. 2009. Origins and evolutionary genom-
ics of the 2009 swine-origin H1N1 influenza A epidemic. 
Nature 459: 1122-1125. 
9 Butler, D. 2009. Swine flu goes global. Nature 458: 
1082-1083. 
10 Cohen, I. and Enserink, M. 2009. Infectious diseases. As 
swine flu circles globe, scientists grapple with basic 
questions. Science 324: 572-573. 
11 Kobasa, D. and Kawaoka, Y. 2005. Emerging influenza 
viruses: past and present. Curr. Mol. Med. 5:791-803. 
12 Obenauer, J.C., et al. 2006. Large-scale sequence analysis 
of avian influenza isolates. Science 311: 1576-1580. 
Salahuddin and Khan / Analysis of NS1 and NS2 Proteins of H1N1 
Genomics Proteomics Bioinformatics 2010 Sep; 8(3): 190-199 198
13 Danishuddin, M., et al. 2009. Molecular interactions 
between mitochondrial membrane proteins and the 
C-terminal domain of PB1-F2: an in silico approach. J. 
Mol. Model. 16: 535-541. 
14 Lamb, R.A., et al. 1980. Mapping of the two overlapping 
genes for polypeptides NS1 and NS2 on RNA segment 8 
of influenza virus genome. Proc. Natl. Acad. Sci. USA 77: 
1857-1861.  
15 Hatada, E., et al. 1997. Binding of the influenza virus 
NS1 protein to model genome RNAs. J. Gen. Virol. 78: 
1059-1063. 
16 Marion, R.M., et al. 1997. The N-terminal half of the in-
fluenza virus NS1 protein is sufficient for nuclear reten-
tion of mRNA and enhancement of viral mRNA transla-
tion. Nucleic Acids Res. 25: 4271-4277. 
17 Marion, R.M., et al. 1997. Influenza virus NS1 protein 
interacts with viral transcription-replication complexes in 
vivo. J. Gen. Virol. 78: 2447-2451. 
18 Qiu, Y. and Krug, R.M. 1994. The influenza virus NS1 
protein is a poly (A)-binding protein that inhibits nuclear 
export of mRNAs containing poly (A). J. Virol. 68: 
2425-2432. 
19 Qiu, Y., et al. 1995. The influenza virus NS1 protein 
binds to a specific region in human U6 snRNA and inhib-
its U6-U2 and U6-U4 snRNA interactions during splicing. 
RNA 1: 304-316. 
20 Lin, D., et al. 2007. Structure and function of the NS1 
protein of influenza A virus. Acta Biochim. Biophys. Sin. 
39: 155-162. 
21 Hale, B.G., et al. 2008. The multifunctional NS1 protein 
of influenza A viruses. J. Gen. Virol. 89: 2359-2376. 
22 Qian, X.Y., et al. 1994. Two functional domains of the in-
fluenza virus NS1 protein are required for regulation of 
nuclear export of mRNA. J. Virol. 68: 2433-2441. 
23 Aragon, T., et al. 2000. Eukaryotic translation initiation 
factor 4GI is a cellular target for NS1 protein, a transla-
tional activator of influenza virus. Mol. Cell Biol. 20: 
6259-6568. 
24 Burgui, I., et al. 2003. PABP1 and eIF4GI associate with 
influenza virus NS1 protein in viral mRNA translation 
initiation complexes. J. Gen. Virol. 84: 3263-3274. 
25 Falcon, A.M., et al. 1999. Interaction of influenza virus 
NS1 protein and the human homologue of Staufen in vivo 
and in vitro. Nucleic Acids Res. 27: 2241-2247. 
26 Nemeroff, M.E., et al. 1998. Influenza virus NS1 protein 
interacts with the cellular 30 kDa subunit of CPSF and 
inhibits 3' end formation of cellular pre-mRNAs. Mol. 
Cell 1: 991-1000. 
27 Wolff, T., et al. 1998. NS1-Binding Protein (NS1-BP): a 
novel human protein that interacts with the influenza A 
virus nonstructural NS1 protein is relocalized in the nu-
clei of infected cells. J. Virol. 72: 7170-7180. 
28 Qian, X.Y., et al. 1995. An amino-terminal polypeptide 
fragment of the influenza virus NS1 protein possesses 
specific RNA-binding activity and largely helical back-
bone structure. RNA 1: 948-956.  
29 Fortes, P., et al. 1994. Influenza virus NS1 protein inhib-
its pre-mRNA splicing and blocks mRNA nucleocyto-
plasmic transport. EMBO J. 13: 704-712.  
30 Fortes, P., et al. 1995. Influenza virus NS1 protein alters 
the subnuclear localization of cellular splicing compo-
nents. J. Gen. Virol. 76: 1001-1007.  
31 Lu, Y., et al. 1994. The influenza virus NS1 protein: a 
novel inhibitor of pre-mRNA splicing. Genes Dev. 8: 
1817-1828.  
32 de la Luna, S., et al. 1995. Influenza virus NS1 protein 
enhances the rate of translation initiation of viral mRNAs. 
J. Virol. 69: 2427-2433.  
33 Enami, K., et al. 1994. Influenza virus NS1 protein 
stimulates translation of the M1 protein. J. Virol. 68: 
1432-1437.  
34 Ludwig, S., et al. 2002. The influenza A virus NS1 pro-
tein inhibits activation of Jun N-terminal kinase and AP-1 
transcription factors. J. Virol. 76: 11166-11171. 
35 Zhirnov, O.P., et al. 2002. NS1 protein of influenza A vi-
rus down-regulates apoptosis. J. Virol. 76: 1617-1625.  
36 Hatada, E., et al. 1999. Mutant influenza viruses with a 
defective NS1 protein cannot block the activation of PKR 
in infected cells. J. Virol. 73: 2425-2433. 
37 Seo, S.H., et al. 2002. Lethal H5N1 influenza viruses es-
cape host anti-viral cytokine responses. Nat. Med. 8: 
950-954. 
38 Richardson, J.C. and Akkina, R.K. 1991. NS2 protein of 
influenza virus is found in purified virus and phosphory-
lated in infected cells. Arch. Virol. 116: 69-80. 
39 O’Neill, R.E., et al. 1998. The influenza virus NEP (NS2 
protein) mediates the nuclear export of viral ribonucleo-
proteins. EMBO J. 17: 288-296. 
40 Neumann, G., et al. 2000. Influenza A virus NS2 protein 
mediates vRNP nuclear export through NES-independent 
interaction with hCRM1. EMBO J. 19: 6751-6758. 
41 Schmitt, A.P. and Lamb, R.A. 2005. Influenza virus as-
sembly and budding at the viral budzone. Adv. Virus. Res. 
64: 383-416. 
42 Robb, N.C., et al. 2009. NS2/NEP protein regulates tran-
scription and replication of the influenza virus RNA ge-
nome. J. Gen. Virol. 90: 1398-1407. 
43 Greenspan, D., et al. 1985. Expression on influenza virus 
NS2 nonstructural protein in bacteria and localization of 
NS2 in infected eukaryotic cells. J. Virol. 54: 833-843. 
44 Ward, A.C., et al. 1995. Expression and analysis of the 
NS2 protein of influenza A virus. Arch. Virol. 140: 
2067-2073. 
45 Akarsu, H., et al. 2003. Crystal structure of the M1 pro-
tein-binding domain of the influenza A virus nuclear ex-
port protein (NEP/NS2). EMBO J. 22: 4646-4555. 
46 Donelan, N.R., et al. 2003. A recombinant influenza A 
virus expressing an RNA-binding defective NS1 protein 
Salahuddin and Khan / Analysis of NS1 and NS2 Proteins of H1N1 
Genomics Proteomics Bioinformatics 2010 Sep; 8(3): 190-199 199
induces high levels of beta interferon and is attenuated in 
mice. J. Virol. 77: 13257-13266. 
47 Wang, X., et al. 2000. Influenza A virus NS1 protein 
prevents activation of NF-kappaB and induction of al-
pha/beta interferon. J. Virol. 74: 11566-11573. 
48 Min, J.Y. and Krug, R.M. 2006. The primary function of 
RNA binding by the influenza A virus NS1 protein in 
infected cells: inhibiting the 2'-5' oligo(A) syn-
thetase/RNase L pathway. Proc. Natl. Acad. Sci. USA 
103: 7100-7105. 
49 Wang, W., et al. 1999. RNA binding by the novel helical 
domain of the influenza virus NS1 protein requires its 
dimer structure and a small number of specific basic 
amino acids. RNA 5: 195-205. 
50 Chien, C.Y., et al. 1997. A novel RNA-binding motif in 
influenza A virus non-structural protein 1. Nat. Struct. 
Biol. 4: 891-895. 
51 Liu, J., et al. 1997. Crystal structure of the unique 
RNA-binding domain of the influenza virus NS1 protein. 
Nat. Struct. Biol. 4: 896-899. 
52 Yin, C., et al. 2007. Conserved surface features form the 
double-stranded RNA binding site of non-structural pro-
tein 1 (NS1) from influenza A and B viruses. J. Biol. 
Chem. 282: 20584-20592. 
53 Seo, S.H., et al. 2004. The NS1 gene of H5N1 influenza 
viruses circumvents the host anti-viral cytokine responses. 
Virus Res. 103: 107-113. 
54 Lipatov, A.S., et al. 2005. Pathogenesis of Hong Kong 
H5N1 influenza virus NS gene reassortants in mice: the 
role of cytokines and B- and T-cell responses. J. Gen. Vi-
rol. 86: 1121-1130. 
55 Li, M. and Wang, B. 2007. Homology modeling and ex-
amination of the effect of the D92E mutation on the 
H5N1 nonstructural protein NS1 effector domain. J. Mol. 
Model. 13: 1237-1244. 
56 Nemeroff, M.E., et al. 1995. The influenza virus NS1 
protein forms multimers in vitro and in vivo. Virology 212: 
422-428. 
57 Richt, J.A., et al. 2006. Vaccination of pigs against swine 
influenza viruses by using an NS1-truncated modified 
live-virus vaccine. J. Virol. 80: 11009-11018. 
58 Solorzano, A., et al. 2005. Mutations in the NS1 protein 
of swine influenza virus impair anti-interferon activity 
and confer attenuation in pigs. J. Virol. 79: 7535-7543. 
59 Vincent, A.L., et al. 2007. Efficacy of intranasal admini-
stration of a truncated NS1 modified live influenza virus 
vaccine in swine. Vaccine 25: 7999-8009. 
60 Richt, J.A. and García-Sastre, A. 2009. Attenuated influ-
enza virus vaccines with modified NS1 proteins. Curr. 
Top. Microbiol. Immunol. 333: 177-195. 
61 Steel, J., et al. 2009. Live attenuated influenza viruses 
containing NS1 truncations as vaccine candidates against 
H5N1 highly pathogenic avian influenza. J. Virol. 83: 
1742-1753. 
 
